Science & Evidence

Ibogaine Research Database

86 peer-reviewed studies indexed from PubMed. Plain-language summaries where available.

All Studies (86)Opioid Addiction (15)Heroin Addiction (15)PTSD (15)Depression (15)Alcohol Addiction (15)Cocaine Addiction (15)Anxiety (13)Methamphetamine Addiction (12)Traumatic Brain Injury (2)

Studies on Opioid Addiction(9)

← Back to Opioid Addiction

Ibogaine for Opioid Use Disorder: An Unrecognized Risk.

Terasaki, Sackett, Monte· Journal of addiction medicine· 2026· PMID: 41535993

The psychedelic substance, ibogaine, has garnered growing interest among policymakers, researchers, and the public in its potential use for opioid use disorder (OUD). Many states are allocating significant funds to investigate it further. However, some proponents of ibogaine are ...

The pharmacokinetics and pharmacodynamics of ibogaine in opioid use disorder patients.

Knuijver, Ter Heine, Schellekens· Journal of psychopharmacology (Oxford, England)· 2024· PMID: 38519421

Ibogaine is a hallucinogenic drug that may be used to treat opioid use disorder (OUD). The relationships between pharmacokinetics (PKs) of ibogaine and its metabolites and their clinical effects on side effects and opioid withdrawal severity are unknown. We aimed to study these r...

Safety of ibogaine administration in detoxification of opioid-dependent individuals: a descriptive open-label observational study.

Knuijver, Schellekens, Belgers· Addiction (Abingdon, England)· 2022· PMID: 33620733

Ibogaine is an indole alkaloid used in rituals of the African Bwiti tribe. It is also used in non-medical settings to treat addiction. However, ibogaine has been linked to several deaths, mainly due to cardiac events called torsades des pointes preceded by QTc prolongation as wel...

Evaluating the toxicity and therapeutic potential of ibogaine in the treatment of chronic opioid abuse.

Luz, Mash· Expert opinion on drug metabolism & toxicology· 2021· PMID: 34139922

Ibogaine and Subjective Experience: Transformative States and Psychopharmacotherapy in the Treatment of Opioid Use Disorder.

Brown, Noller, Denenberg· Journal of psychoactive drugs· 2019· PMID: 30967101

This article examines the therapeutic potential of ibogaine, a powerful oneiric alkaloid derived from Tabernanthe iboga, through exploring the subjective experiences of 44 participants from two observational treatment studies for opioid use disorder. Following treatment with ibog...

Ibogaine as a treatment for substance misuse: Potential benefits and practical dangers.

Corkery· Progress in brain research· 2018· PMID: 30471681

Ibogaine is an indole alkaloid found in the root bark of the Iboga shrub native to west Africa possessing hallucinogenic properties. For centuries it has been used in religious ceremonies and to gain spiritual enlightenment. However, since the early 1960s, its apparent ability to...

Ibogaine Detoxification Transitions Opioid and Cocaine Abusers Between Dependence and Abstinence: Clinical Observations and Treatment Outcomes.

Mash, Duque, Page· Frontiers in pharmacology· 2018· PMID: 29922156

Ibogaine may be effective for transitioning opioid and cocaine dependent individuals to sobriety. American and European self-help groups provided public testimonials that ibogaine alleviated drug craving and opioid withdrawal symptoms after only a single dose administration. Prec...

Ibogaine treatment outcomes for opioid dependence from a twelve-month follow-up observational study.

Noller, Frampton, Yazar-Klosinski· The American journal of drug and alcohol abuse· 2018· PMID: 28402682

The psychoactive indole alkaloid ibogaine has been associated with encouraging treatment outcomes for opioid dependence. The legal status of ibogaine in New Zealand provides a unique opportunity to evaluate durability of treatment outcomes. To examine longitudinal treatment effec...

How toxic is ibogaine?

Litjens, Brunt· Clinical toxicology (Philadelphia, Pa.)· 2016· PMID: 26807959

Ibogaine is a psychoactive indole alkaloid found in the African rainforest shrub Tabernanthe Iboga. It is unlicensed but used in the treatment of drug and alcohol addiction. However, reports of ibogaine's toxicity are cause for concern. To review ibogaine's pharmacokinetics and p...